FDA grants to boost manufacturing, regulatory science

The FDA has made a potential $35 million commitment that aims to improve both drug-making and regulation. The goal of the FDA grants to the National Institute for Pharmaceutical Technology and Education (NIPTE) is to improve drug manufacturing standards.

"Investment in research of drug development and manufacturing will improve America's manufacturing competitiveness and create high-paying jobs at home," according to an NIPTE statement. It will also "help to reverse" offshoring and outsourcing trends by decreasing the cost of manufacture and by improving quality and safety of drugs.

"Progress in this area will mean safer, more efficient and less costly drug production here in the U.S.," says Helen Winkle, director for FDA's Office of Pharmaceutical Sciences, in the statement.

The nonprofit NIPTE says its goal is to "increase science and engineering-based understanding" of drug manufacturing so "novel" technologies can be developed and science-based regulations can be implemented.

- here's the statement

Suggested Articles

Colorado is making a play for a Japanese CDMO in hopes it will invest about $100 million in an empty AstraZeneca plant in Boulder.

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.